Sabra Health Care REIT, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SBRA research report →
Companywww.sabrahealth.com
As of March 31, 2022, Sabra's investment portfolio included 416 real estate properties held for investment. This consists of (i) 279 Skilled Nursing/Transitional Care facilities, (ii) 59 Senior Housing communities (Senior Housing - Leased), (iii) 50 Senior Housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed), (iv) 13 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), one asset held for sale, one investment in a sales-type lease, 16 investments in loans receivable (consisting of (i) two mortgage loans, (ii) one construction loan and (iii) 13 other loans), seven preferred equity investments and one investment in an unconsolidated joint venture. As of March 31, 2022, Sabra's real estate properties held for investment included 41,445 beds/units, spread across the United States and Canada.
- CEO
- Richard K. Matros
- IPO
- 2002
- Employees
- 50
- HQ
- Irvine, CA, US
Price Chart
Valuation
- Market Cap
- $5.33B
- P/E
- 34.11
- P/S
- 6.56
- P/B
- 1.91
- EV/EBITDA
- 18.03
- Div Yield
- 5.68%
Profitability
- Gross Margin
- 63.48%
- Op Margin
- 28.98%
- Net Margin
- 19.21%
- ROE
- 5.61%
- ROIC
- 4.16%
Growth & Income
- Revenue
- $774.63M · 10.15%
- Net Income
- $155.61M · 22.81%
- EPS
- $0.64 · 18.52%
- Op Income
- $263.87M
- FCF YoY
- 12.26%
Performance & Tape
- 52W High
- $21.28
- 52W Low
- $17.08
- 50D MA
- $20.32
- 200D MA
- $19.28
- Beta
- 0.65
- Avg Volume
- 2.28M
Get TickerSpark's AI analysis on SBRA
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Start Free Trial →Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 25, 26 | FLORES JESSICA | sell | 15,231 |
| Feb 27, 26 | Malehorn Jeffrey A. | other | 781 |
| Feb 27, 26 | Kono Ann | other | 781 |
| Feb 27, 26 | KATZMANN LYNNE S | other | 781 |
| Feb 27, 26 | FOSTER MICHAEL J | other | 781 |
| Feb 27, 26 | Cusack Catherine | other | 781 |
| Feb 27, 26 | Barbarosh Craig A. | other | 781 |
| Feb 27, 26 | FLORES JESSICA | other | 368 |
| Feb 27, 26 | Smith Darrin | other | 478 |
| Feb 27, 26 | Costa Michael Lourenco | other | 4,005 |
Our SBRA Coverage
We haven't published any research on SBRA yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate SBRA Report →